No takes yet. Share an insight, caveat, or question.
Research demonstrates a joint modeling framework for competing risks in nested case-control studies, enhancing biomarker analysis efficiency.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: